Contact
Please use this form to send email to PR contact of this press release:
NeuroCytonix Launches Clinical Trial Studying Its NeuroCytotron Protocol for Autism
TO:
Laurent Lavigne du Cadet
NeuroCytonix
+1 240-243-6446